These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 36344998)

  • 21. Home Gardening of Yellow Cassava and Orange Maize for the Prevention of Nutritional Blindness in Children: An Economic Evaluation and Value of Information Analysis.
    Esio-Bassey C; Wilson ECF; Hooper L; Rao N; Whitty JA
    Value Health Reg Issues; 2023 Nov; 38():77-84. PubMed ID: 37619437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of a Contact Intervention and a Psychotherapeutic Program for Post-discharge Suicide Prevention.
    Martínez-Alés G; Cruz Rodríguez JB; Lázaro P; Domingo-Relloso A; Barrigón ML; Angora R; Rodríguez-Vega B; Jiménez-Sola E; Sánchez-Castro P; Román-Mazuecos E; Villoria L; Ortega AJ; Navío M; Stanley B; Rosenheck R; Baca-García E; Bravo-Ortiz MF
    Can J Psychiatry; 2021 Aug; 66(8):737-746. PubMed ID: 33317338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal control and cost-effective analysis of malaria/visceral leishmaniasis co-infection.
    Agusto FB; ELmojtaba IM
    PLoS One; 2017; 12(2):e0171102. PubMed ID: 28166308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accounting for aetiology: can regional surveillance data alongside host biomarker-guided antibiotic therapy improve treatment of febrile illness in remote settings?
    Chandna A; White LJ; Pongvongsa T; Mayxay M; Newton PN; Day NPJ; Lubell Y
    Wellcome Open Res; 2019; 4():1. PubMed ID: 31245630
    [No Abstract]   [Full Text] [Related]  

  • 25. Practical metrics for establishing the health benefits of research to support research prioritisation.
    Woods B; Schmitt L; Rothery C; Phillips A; Hallett TB; Revill P; Claxton K
    BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32868268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of malaria positivity using patients' demographic and environmental features and clinical symptoms to complement parasitological confirmation before treatment.
    Ojurongbe TA; Afolabi HA; Bashiru KA; Sule WF; Akinde SB; Ojurongbe O; Adegoke NA
    Trop Dis Travel Med Vaccines; 2023 Dec; 9(1):24. PubMed ID: 38098124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
    Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
    Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achieving malaria testing and treatment targets for children under five in Mozambique: a cost-effectiveness analysis.
    Avanceña ALV; Miller A; Canana N; Dula J; Saifodine A; Cadrinho B; Maffioli EM
    Malar J; 2022 Nov; 21(1):320. PubMed ID: 36344998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moving towards malaria elimination in southern Mozambique: Cost and cost-effectiveness of mass drug administration combined with intensified malaria control.
    Cirera L; Galatas B; Alonso S; Paaijmans K; Mamuquele M; Martí-Soler H; Guinovart C; Munguambe H; Luis F; Nhantumbo H; Montañà J; Bassat Q; Candrinho B; Rabinovich R; Macete E; Aide P; Alonso P; Saúte F; Sicuri E
    PLoS One; 2020; 15(7):e0235631. PubMed ID: 32628741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost and cost-effectiveness of indoor residual spraying with pirimiphos-methyl in a high malaria transmission district of Mozambique with high access to standard insecticide-treated nets.
    Alonso S; Chaccour CJ; Wagman J; Candrinho B; Muthoni R; Saifodine A; Saute F; Robertson M; Zulliger R
    Malar J; 2021 Mar; 20(1):143. PubMed ID: 33691706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar.
    Chen IT; Aung T; Thant HN; Sudhinaraset M; Kahn JG
    Malar J; 2015 Feb; 14():55. PubMed ID: 25653121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi.
    Niyibitegeka F; Thavorncharoensap M; Riewpaiboon A; Youngkong S
    Appl Health Econ Health Policy; 2022 Sep; 20(5):707-716. PubMed ID: 35469393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What next after GDP-based cost-effectiveness thresholds?
    Chi YL; Blecher M; Chalkidou K; Culyer A; Claxton K; Edoka I; Glassman A; Kreif N; Jones I; Mirelman AJ; Nadjib M; Morton A; Norheim OF; Ochalek J; Prinja S; Ruiz F; Teerawattananon Y; Vassall A; Winch A
    Gates Open Res; 2020; 4():176. PubMed ID: 33575544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds.
    Daroudi R; Akbari Sari A; Nahvijou A; Faramarzi A
    Cost Eff Resour Alloc; 2021 Feb; 19(1):7. PubMed ID: 33541364
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.